Seroatlas · Human Serome Atlas

ANXA9

Annexin A9

Also known as: ANX31, ANXA9_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
O76027
Gene
ANXA9
Ensembl
ENSG00000143412
Chromosome
1
Canonical length
345 aa
Protein class
Predicted intracellular proteins
Subcellular location
Nuclear speckles,Cytosol
Quaternary structure
Homodimer

OverviewNCBI Gene

The annexins are a family of calcium-dependent phospholipid-binding proteins. Members of the annexin family contain 4 internal repeat domains, each of which includes a type II calcium-binding site. The calcium-binding sites are required for annexins to aggregate and cooperatively bind anionic phospholipids and extracellular matrix proteins. This gene encodes a divergent member of the annexin protein family in which all four homologous type II calcium-binding sites in the conserved tetrad core contain amino acid substitutions that ablate their function. However, structural analysis suggests that the conserved putative ion channel formed by the tetrad core is intact. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

345 residues, UniProt reviewed canonical sequence.

>O76027|ANXA9
     1  MSVTGGKMAP SLTQEILSHL GLASKTAAWG TLGTLRTFLN FSVDKDAQRL LRAITGQGVD
    61  RSAIVDVLTN RSREQRQLIS RNFQERTQQD LMKSLQAALS GNLERIVMAL LQPTAQFDAQ
   121  ELRTALKASD SAVDVAIEIL ATRTPPQLQE CLAVYKHNFQ VEAVDDITSE TSGILQDLLL
   181  ALAKGGRDSY SGIIDYNLAE QDVQALQRAE GPSREETWVP VFTQRNPEHL IRVFDQYQRS
   241  TGQELEEAVQ NRFHGDAQVA LLGLASVIKN TPLYFADKLH QALQETEPNY QVLIRILISR
   301  CETDLLSIRA EFRKKFGKSL YSSLQDAVKG DCQSALLALC RAEDM

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against ANXA9 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.28
Highest tissue expression
34 nTPM

Expression across tissuesHPA

Tissue

  • pancreas: 34 nTPM
  • skin: 31 nTPM
  • liver: 28 nTPM
  • esophagus: 25 nTPM
  • thyroid gland: 23 nTPM
  • tonsil: 22 nTPM

Single-cell type

  • esophageal apical cells: 393 nCPM
  • cholangiocytes: 76 nCPM
  • pancreatic duct cells: 66 nCPM
  • epididymal efferent duct absorptive cells: 36 nCPM
  • prostatic club cells: 29 nCPM
  • hepatocytes: 17 nCPM

Immune cell

  • myeloid DC: 1.6 nTPM
  • classical monocyte: 1.2 nTPM
  • neutrophil: 1 nTPM
  • eosinophil: 0.7 nTPM
  • intermediate monocyte: 0.7 nTPM
  • total PBMC: 0.4 nTPM

Brain region

  • white matter: 31 nTPM
  • medulla oblongata: 26 nTPM
  • basal ganglia: 21 nTPM
  • midbrain: 21 nTPM
  • cerebellum: 20 nTPM
  • pons: 19 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.43
gnomAD pLI
0
gnomAD missense Z
0.34
DepMap mean gene effect
-0.14
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of ANXA9 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads ANXA9 as an antibody target. Whether an autoantibody or antibody against ANXA9 could matter depends on whether native ANXA9 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

ANXA9 is annotated at the cell surface, where native ANXA9 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label ANXA9 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/ANXA9. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...